Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Long-Term Investments: 2016

Historic Long-Term Investments for Niagen Bioscience (NAGE) over the last 1 years, with Dec 2016 value amounting to $20,318.

  • Niagen Bioscience's Long-Term Investments was N/A to $20,318 in Q4 2016 from the same period last year, while for Dec 2016 it was $20,318, marking a year-over-year change of. This contributed to the annual value of $20,318 for FY2016, which is N/A change from last year.
  • As of FY2016, Niagen Bioscience's Long-Term Investments stood at $20,318.
  • In the past 5 years, Niagen Bioscience's Long-Term Investments ranged from a high of $20,318 in FY2016 and a low of $20,318 during FY2016.
  • Over the past 1 years, Niagen Bioscience's median Long-Term Investments value was $20,318 (recorded in 2016), while the average stood at $20,318.